What is the size of Genome Sequencing Market?
According to 6Wresearch internal database and industry insights,
Global Genome Sequencing Market was estimated at
USD 15 Billion in 2024 and is expected to reach
USD 30 Billion by 2031, growing at a
CAGR of 12.8% during the forecast period 2025â2031.
The genome sequencing market is expected to rise rapidly due to growth factors including the rising adoption of precision medicine, declining sequencing costs, and growing applications in diagnostics, drug discovery, and agriculture.
Key Growth Drivers of the Genome Sequencing Market
- Rising demand for early disease detection and personalized treatments
- Rapid advancements in sequencing technologies and data analytics
- Increased government and private investments in genomics research
- Expanding use of genome sequencing in oncology, rare diseases, and reproductive health
- Growing need for agricultural genomics and biosecurity
Genome Sequencing Market Trends
Genome Sequencing Market is witnessing a shift toward affordable and ultra-fast next-generation sequencing (NGS) platforms. Other trends such as cloud-based platforms are gaining popularity for genomic data storage and analysis. Clinical adoption of whole genome and whole exome sequencing is rising for diagnostic accuracy. Multi-omics approaches are being integrated to deliver deeper biological insights. Consumers are focusing on genome services which became more accessible and affordable.
Emerging Developments in the Genome Sequencing Market
Genome sequencing market is moving forward with developments include portable sequencing devices for field diagnostics, AI-powered tools for variant interpretation, and real-time sequencing for rapid clinical decisions. Now, the companies are investing in long-read sequencing technologies for improved genome assembly and complex variant detection. New business models like sequencing-as-a-service (SaaS) are emerging. The researchers are focusing on paediatric and neonatal genome sequencing for early-onset disorders.
Leading Companies in the Genome Sequencing Market
- Illumina, Inc.
- Thermo Fisher Scientific
- Pacific Biosciences
- Oxford Nanopore Technologies
- BGI Genomics
- F. Hoffmann-La Roche Ltd
- QIAgen
- Agilent Technologies
- Eurofins Scientific
- PerkinElmer
How Big is the Genome Sequencing Market : FAQs
The genome sequencing market was estimated at USD 15 Billion in 2024 and is expected to reach USD 30 Billion by 2031.
The genome sequencing market is expected to grow at a CAGR of 12.8% from 2025 to 2031.
Primary drivers include personalized healthcare demand, falling sequencing costs, and expanding diagnostic applications.
Leading companies include Illumina, Thermo Fisher Scientific, Oxford Nanopore, and Pacific Biosciences.
6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on
sales@6wresearch.com